Skip to content
← Back to this collection

PUBLICATIONS · 35839426

Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2022 Dec 10
First author
Desai AV

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Desai AV
      type
      Author
    2. name
      Gilman AL
      type
      Author
    3. name
      Ozkaynak MF
      type
      Author
    4. name
      Naranjo A
      type
      Author
    5. name
      London WB
      type
      Author
    6. name
      Tenney SC
      type
      Author
    7. name
      Diccianni M
      type
      Author
    8. name
      Hank JA
      type
      Author
    9. name
      Parisi MT
      type
      Author
    10. name
      Shulkin BL
      type
      Author
    11. name
      Smith M
      type
      Author
    12. name
      Moscow JA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Desai AV
      type
      Author
    2. name
      Gilman AL
      type
      Author
    3. name
      Ozkaynak MF
      type
      Author
    4. name
      Naranjo A
      type
      Author
    5. name
      London WB
      type
      Author
    6. name
      Tenney SC
      type
      Author
    7. name
      Diccianni M
      type
      Author
    8. name
      Hank JA
      type
      Author
    9. name
      Parisi MT
      type
      Author
    10. name
      Shulkin BL
      type
      Author
    11. name
      Smith M
      type
      Author
    12. name
      Moscow JA
      type
      Author
    bibliography ids
    1. nci-bib-4723875d856c4824eaadfe9a
    book metadata
    content sha256
    e7e5cc1584868f0ff5545252e237524c1454630b8c22b83ea8b2c0f57e6719f4
    document type
    citation
    dois
    1. 10.1200/JCO.21.02478
    electronic publication date
    display
    2022 Jul 15
    precision
    day
    year
    2022
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35839426
    immutable id
    pubmed:35839426@e7e5cc1584868f0ff5545252e237524c1454630b8c22b83ea8b2c0f57e6719f4
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    35
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    4107-4118
    volume
    40
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35839426
      provenance
      batch id
      9d150d55960e0c12aada
      provider
      NCBI PubMed ESummary
      record sha256
      c8ec0b60bd2561bb0b99ee0a45236f5e112c22be94001287a8e0155711613440
      response sha256
      2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
      retrieved at
      2026-09-09T23:48:09.820498+00:00
      publication date
      display
      2022 Dec 10
      precision
      day
      year
      2022
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35839426/
      title
      Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group.

      Preserved source evidence · Not medical advice